Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 16.28 Million EUR | 16.07% |
| 2022 | 14.03 Million EUR | -11.59% |
| 2021 | 15.87 Million EUR | 6.99% |
| 2020 | 14.83 Million EUR | 51.0% |
| 2019 | 9.82 Million EUR | 48.38% |
| 2018 | 6.62 Million EUR | 14.85% |
| 2017 | 5.76 Million EUR | -7.11% |
| 2016 | 6.2 Million EUR | -0.23% |
| 2015 | 6.21 Million EUR | 119.13% |
| 2014 | 2.83 Million EUR | -10.87% |
| 2013 | 3.18 Million EUR | 12.19% |
| 2012 | 2.83 Million EUR | 11.12% |
| 2011 | 2.55 Million EUR | 46.36% |
| 2010 | 1.74 Million EUR | 28.78% |
| 2009 | 1.35 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 14.81 Million EUR | 0.0% |
| 2023 Q2 | 18.09 Million EUR | 3.46% |
| 2023 Q1 | 17.49 Million EUR | 24.68% |
| 2023 Q4 | 16.28 Million EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | 16.28 Million EUR | 16.07% |
| 2022 Q3 | 14.79 Million EUR | -11.71% |
| 2022 Q2 | 16.76 Million EUR | 3.9% |
| 2022 Q1 | 16.13 Million EUR | 1.65% |
| 2022 FY | 14.03 Million EUR | -11.59% |
| 2022 Q4 | 14.03 Million EUR | -5.19% |
| 2021 Q3 | 15.22 Million EUR | -4.92% |
| 2021 Q2 | 16 Million EUR | 2.16% |
| 2021 FY | 15.87 Million EUR | 6.99% |
| 2021 Q4 | 15.87 Million EUR | 4.26% |
| 2021 Q1 | 15.66 Million EUR | 5.64% |
| 2020 Q3 | 14.16 Million EUR | 76.71% |
| 2020 Q1 | 7.81 Million EUR | -20.45% |
| 2020 FY | 14.83 Million EUR | 51.0% |
| 2020 Q2 | 8.01 Million EUR | 2.57% |
| 2020 Q4 | 14.83 Million EUR | 4.73% |
| 2019 FY | 9.82 Million EUR | 48.38% |
| 2019 Q4 | 9.82 Million EUR | 2.52% |
| 2019 Q1 | 7.36 Million EUR | 11.19% |
| 2019 Q2 | 7.7 Million EUR | 4.62% |
| 2019 Q3 | 9.58 Million EUR | 24.43% |
| 2018 Q1 | 6.41 Million EUR | 11.29% |
| 2018 Q2 | 6.41 Million EUR | 0.0% |
| 2018 FY | 6.62 Million EUR | 14.85% |
| 2018 Q4 | 6.62 Million EUR | 0.0% |
| 2018 Q3 | 6.61 Million EUR | 3.2% |
| 2017 FY | 5.76 Million EUR | -7.11% |
| 2017 Q4 | 5.76 Million EUR | 0.0% |
| 2017 Q3 | 5.76 Million EUR | -5.94% |
| 2017 Q2 | 6.12 Million EUR | 0.0% |
| 2017 Q1 | 6.12 Million EUR | -1.24% |
| 2016 Q4 | 6.2 Million EUR | 0.02% |
| 2016 Q2 | 6.14 Million EUR | 0.0% |
| 2016 Q3 | 6.2 Million EUR | 0.94% |
| 2016 Q1 | 6.14 Million EUR | -1.17% |
| 2016 FY | 6.2 Million EUR | -0.23% |
| 2015 Q4 | 6.21 Million EUR | 0.0% |
| 2015 FY | 6.21 Million EUR | 119.13% |
| 2015 Q3 | 6.21 Million EUR | 31.76% |
| 2015 Q2 | 4.72 Million EUR | 0.0% |
| 2015 Q1 | 4.72 Million EUR | 66.31% |
| 2014 FY | 2.83 Million EUR | -10.87% |
| 2014 Q4 | 2.83 Million EUR | -41.0% |
| 2014 Q3 | 4.81 Million EUR | 77.49% |
| 2014 Q2 | 2.71 Million EUR | 0.0% |
| 2014 Q1 | 2.71 Million EUR | -14.89% |
| 2013 Q2 | 2.29 Million EUR | 0.0% |
| 2013 FY | 3.18 Million EUR | 12.19% |
| 2013 Q3 | 3.18 Million EUR | 38.86% |
| 2013 Q4 | 3.18 Million EUR | 0.0% |
| 2013 Q1 | 2.29 Million EUR | -19.2% |
| 2012 FY | 2.83 Million EUR | 11.12% |
| 2012 Q2 | 2.44 Million EUR | 0.0% |
| 2012 Q4 | 2.83 Million EUR | 0.0% |
| 2011 Q2 | 1.1 Million EUR | 0.0% |
| 2011 Q4 | 2.55 Million EUR | 0.0% |
| 2011 FY | 2.55 Million EUR | 46.36% |
| 2010 FY | 1.74 Million EUR | 28.78% |
| 2010 Q4 | 1.74 Million EUR | 0.0% |
| 2010 Q2 | 2 Million EUR | 0.0% |
| 2009 Q4 | 1.35 Million EUR | 0.0% |
| 2009 Q2 | 2.52 Million EUR | 0.0% |
| 2009 FY | 1.35 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Affluent Medical SA | 17.13 Million EUR | 4.955% |
| Bluelinea Société Anonyme | 3.61 Million EUR | -349.93% |
| Carmat SA | 57.64 Million EUR | 71.751% |
| Euromedis Groupe | 10.01 Million EUR | -62.57% |
| Eurobio Scientific Société anonyme | 100.63 Million EUR | 83.817% |
| Ikonisys S.A. | 3.2 Million EUR | -407.716% |
| Implanet S.A. | 6.15 Million EUR | -164.754% |
| Median Technologies SA | 23.01 Million EUR | 29.236% |
| SpineGuard SA | 3.08 Million EUR | -427.86% |
| Theraclion SA | 1.95 Million EUR | -734.813% |
| Euroapi S.A. | 225.5 Million EUR | 92.778% |
| Guerbet SA | 383.87 Million EUR | 95.758% |
| Ion Beam Applications SA | 41.58 Million EUR | 60.837% |
| Koninklijke Philips N.V. | 7.68 Billion EUR | 99.788% |
| Sequana Medical NV | 16.78 Million EUR | 2.99% |